Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huadan Anshen Mixture is a traditional Chinese medicine (TCM) hospital preparation developed by the Shanghai Traditional Chinese Medicine Hospital for the treatment of insomnia. The formulation is designed to soothe the liver, relieve depression, nourish the heart, and calm the mind. It is typically prescribed for patients suffering from sleep disorders associated with TCM syndromes such as liver qi stagnation or heart-spleen deficiency. As a liquid oral mixture, it combines several botanical extracts, notably including *Albizia julibrissin* (He Huan Hua) and *Salvia miltiorrhiza* (Dan Shen), which are traditionally used in Chinese medicine to regulate mood and improve sleep quality. In the Chinese regulatory context, it is classified as a medical institution preparation (医疗机构制剂), allowing it to be prescribed and used within the hospital's clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huadan Anshen Mixture.